These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25060643)

  • 1. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
    Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
    Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
    Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
    Front Immunol; 2018; 9():724. PubMed ID: 29719533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
    Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
    Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
    Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.
    Asghar K; Loya A; Rana IA; Abu Bakar M; Farooq A; Tahseen M; Ishaq M; Rashid MU
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3521-3525. PubMed ID: 31759380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium attenuates d-amphetamine-induced hyperlocomotor activity in mice via inhibition of interaction between cyclooxygenase-2 and indoleamine-2,3-dioxygenase.
    Phan DH; Shin EJ; Jeong JH; Tran HQ; Sharma N; Nguyen BT; Jung TW; Nah SY; Saito K; Nabeshima T; Kim HC
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):790-797. PubMed ID: 31883280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
    Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
    Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells.
    Iachininoto MG; Nuzzolo ER; Bonanno G; Mariotti A; Procoli A; Locatelli F; De Cristofaro R; Rutella S
    Molecules; 2013 Aug; 18(9):10132-45. PubMed ID: 23973990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
    Zhao Y; Wei L; Liu J; Li F
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cyclooxygenase-2 expression levels and metalloproteinase 2 and 9 activation by Hexachlorobenzene in human endometrial stromal cells.
    Chiappini F; Bastón JI; Vaccarezza A; Singla JJ; Pontillo C; Miret N; Farina M; Meresman G; Randi A
    Biochem Pharmacol; 2016 Jun; 109():91-104. PubMed ID: 27038655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
    Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
    Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP4 receptor promotes invadopodia and invasion in human breast cancer.
    Tönisen F; Perrin L; Bayarmagnai B; van den Dries K; Cambi A; Gligorijevic B
    Eur J Cell Biol; 2017 Mar; 96(2):218-226. PubMed ID: 28094049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
    Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM
    Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
    Kundu N; Ma X; Kochel T; Goloubeva O; Staats P; Thompson K; Martin S; Reader J; Take Y; Collin P; Fulton A
    Breast Cancer Res Treat; 2014 Jan; 143(1):19-31. PubMed ID: 24281828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.